Organigram

Moncton, CanadaFounded 2013

Producer & Grower NASDAQ: OGI www.organigram.ca

Share:X / Twitter LinkedIn Suggest a correction

About Organigram

Organigram is a Moncton, New Brunswick-based licensed producer known for its innovation-driven approach to cannabis production. The company received a strategic investment from British American Tobacco and has been recognized for leading market share in several Cannabis 2.0 product categories including edibles and vapes.

Key Facts

1British American Tobacco invested CAD $221 million for a 19.9% stake, with a product development collaboration
2SHRED brand became one of the best-selling cannabis products in Canada
3Operates a state-of-the-art indoor cultivation facility in Moncton, New Brunswick
4Invested in Jupiter Research for next-generation vape technology

Latest News

Major Cannabis Stocks Plunge on Rescheduling Reality Check

5d ago

TLRY, CGC, ACB, CRON, and OGI tumble as investors reassess limited impact of federal cannabis reclassification on Canadian operators and market fundamentals.

Cannabis Stocks Plunge as Rescheduling Optimism Fades

5d ago

Major cannabis operators including TLRY, CGC, and ACB tumble as investors reassess limited impact from federal reclassification prospects.

Organigram Stock Faces U.S. Market Scrutiny Amid Cannabis Expansion

9d ago

OGI's cannabis-focused strategy draws mixed reactions from U.S. investors as regulatory uncertainty clouds growth prospects in key markets.

OGI Stock: Can Organigram's Cannabis Strategy Win U.S. Investors?

9d ago

Organigram Holdings faces scrutiny as investors question whether its cannabis-focused approach can deliver returns in an increasingly competitive North American market.

View all OGI news

Frequently Asked Questions

What is the SHRED brand?

SHRED is Organigram's highly successful milled flower brand that disrupted the Canadian cannabis market with its ready-to-roll format, becoming one of the top-selling cannabis SKUs nationally.

What is Organigram's relationship with BAT?

British American Tobacco invested CAD $221 million for a 19.9% stake in Organigram and established a product development collaboration called the Centre of Excellence to develop next-generation cannabis products.